The use of a combination of Ki-67, galectin-3, and PTTG can distinguish the benign and malignant thyroid tumor

Clinical Laboratory

Volumn 58, Issue 5-6, 2012, Pages 419-426

  Cui, Wenli ^a   Lu, Xiaomei ^a   Zheng, Shutao ^a   Ma, Yuqing ^a   Liu, Xia ^a   Zhang, Wei ^a  

^a XINJIANG MEDICAL UNIVERSITY   (China)

Author keywords

Galectin 3; Immunohistochemistry; Ki 67; PTTG; Thyroid tumor

Indexed keywords

GALECTIN 3; KI 67 ANTIGEN; PITUITARY TUMOR TRANSFORMING PROTEIN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FOLLICULAR CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PAPILLARY CARCINOMA; PREDICTIVE VALUE; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; THYROID TUMOR; TUMOR DIFFERENTIATION;

ADENOCARCINOMA, FOLLICULAR; ADENOCARCINOMA, PAPILLARY; ADENOMA; GALECTIN 3; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; NEOPLASM PROTEINS; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84863657780     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Baloch ZW, LiVolsi VA. Follicular-pattemed lesions of the thyroid: The bane of the pathologist. Am J Clin Pathol 2002;117:143-50. (Pubitemid 34052484)
2. Baloch ZW, Gupta PK, Yu GH, et al. Follicular variant of papillary carcinoma: cytologic and histologic correlation. Am J Clin Pathol 1999;111:216-22. (Pubitemid 29054949)
3. Williams ED, Abrosimov A, Bogdanova TI, et al. Two proposals regarding the terminology of thyroid tumors [editorial]. Int J Surg Pathol 2000;8: 181-3.
4. LiVolsi VA. Current concepts in follicular tumors of the thyroid. Monogr Pathol 1993;35:118-37.
5. LiVolsi VA, Asa SL. The demise of follicular carcinoma of the thyroid gland. Thyroid 1994;4:233-6.
6. Baloch ZW, LiVolsi VA. The quest for a magic tumor marker. Am J Clin Pathol 2002;118:165-6.
7. Baloch ZW, Abraham S, Robert S, et al. Differential expression of cytokeratins in follicular variant of papillary carcinoma: an immunohistochemical study and its diagnostic utility. Hum Pathol 1999;30:1166-71. (Pubitemid 29480884)
8. Tan A, Etit D, Bayol U, et al. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma. Ann Diagn Pathol 2011;15:108-16.
9. Faggiano A, Coulot J, Bellon N, et al. Age-dependent variation of follicular size and expression of iodine transporters in human thyroid tissue J Nucl Med 2004;45:232-7. (Pubitemid 47618642)
10. Smith VE, Franklyn JA, McCabe CJ. Pituitary tumor-transforming gene and its binding factor in endocrine cancer. Expert Rev Mol Med 2010;12:e38.
11. Sánchez-Ortiga R, Sánchez Tejada L, Peiró Cabrera G, et al. Role of pituitary tumor-transforming gene (PTTG) in the pituitary adenomas. Endocrinol Nutr 2010;57:28-34.
12. Saggiorato E, De Pompa, Volante M, et al. Characterization of thyroid "follicular neoplasms"in fine needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr Relat Cancer 2005;12:305-17.
13. Weber KB, Shroyer KR, Heinz DE, et al. The use of a combination of Galectin-3, and Thyroid peroxidase for the Diagnosis and Prognosis of Thyroid Cancer. Am J Clin Pathol 2004;122:524-31. (Pubitemid 39281248)
14. Baloch ZW, LiVolsi VA. The quest for a magic tumor marker: Continuing saga in the diagnosis of the follicular lesions. Am J Clin Pathol 2002;118:165-6. (Pubitemid 44698438)
15. Aratake Y, Nomura H, Kotani T, et al. Coexistent anaplastic and differentiated thyroid carcinoma: an immunohistochemical study. Am J Clin Pathol 2006;125:399-406. (Pubitemid 43327709)
16. Liang H, Zhong Y, Luo Z, et al. Assessment of biomarkers for clinical diagnosis of papillary thyroid carcinoma with distant metastasis. Int J Biol Markers 2010;25:38-45.
17. Boelaert K, McCabe CJ, Tannahill LA, et al. Pituitary tumor transforming gene and fibroblast growth factor-3 expression: potential prognostic indicators in differentiated thyroid cancer. J Clin Endocrinol Metab 2003;88:2341-7. (Pubitemid 36549916)